$13.5 million awarded in Dana-Farber Cancer Institute death
The family of a 40-year-old woman who died following a cycle of experimental chemotherapy at the Dana-Farber Cancer Institute in Boston was awarded a total of $13.5 million. The jurors decided that her death could have been prevented if Dana-Farber doctors had investigated the cause of chronic diarrhea that surfaced during an unusual treatment protocol for a tumor behind her knee.
- Patient Harm Data to Remain on Medicare's Hospital Compare Site
- Quiet ORs Better for Patient Safety
- Tavenner Confirmed as CMS Administrator
- Leapfrog Hospital Safety Scores 'Depressing'
- Building a Better Healthcare Board
- CMS Seeks to 'Rapidly Reduce' Medicare Spending with $1B in Grants
- Hard-Nosed About Physician Teamwork
- Healthcare Leaders Sound Off on Organized Labor
- Esther Dyson's Population Health Dream
- Case Study: Advance Care Conversations